Completed Pregnancy, Children & Inherited Conditions Diabetes, Hormones & Metabolism

The Role of Endogenous Vascular Protection Factors in Preeclampsia

In plain English

AI plain-English summary

Every week in the UK, hundreds of pregnant women develop dangerously high blood pressure with no warning, because the only way to spot preeclampsia is to catch it during routine antenatal checks. The condition affects roughly one in ten pregnancies overall and one in fifty severely, and it can kill both mother and baby if it goes undetected. The only cure is delivery, which forces some babies to be born dangerously early. Recently, scientists found that certain chemicals in the blood—anti-angiogenic factors—appear to trigger the onset of preeclampsia, but no one knows what controls them. This project aims to identify the natural mechanisms that regulate those harmful factors. If the researchers can find ways to block them, it could lead to a preventative treatment that spares women the risk of sudden severe illness and babies the danger of premature birth. This is fundamental science with a clear clinical target: understanding how the body’s own protective systems work in pregnancy, so doctors can intervene before symptoms appear.

View original technical description
Preeclampsia is the most common of the serious complications of pregnancy. It is caused by a defect in the placenta and is symptomless in the early stages. It is currently only detectable by regular antenatal checks on the mother s blood pressure and urine. In its widest forms, preeclampsia affects about 1 in 10 pregnancies overall and 1 in 50 pregnancies severely. It is potentially life-threatening to mother and baby if allowed to develop and progress undetected. Preeclampsia is curable only by delivery, which puts some babies at risk if they have to be delivered prematurely. Recently, scientists have identified chemicals in the blood (anti-angiogenic factors) that appear to be associated with the onset of preeclampsia. However, it is not known what regulate these anti-angiogenic factors. If we can identify novel mechanisms to inhibit these factors, we could provide preventative treatment.

View the original record at the funder ↗

Researchers

Asif Ahmed (Principal Investigator)

Related Research

Grants with similar aims, by meaning.

Angiogenic Biomarkers as Predictive Tests for Early Onset Preeclampsia: A Population-Based Study
A new approach to an old problem: The roles of aldosterone and salt in normal pregnancy and pre-eclampsia
Pathophysiology of pre-eclampsia - role of vascular growth factors
Precision Biomarkers of pre-eclampsia
The modulation of p53 in correcting aberrant placental apoptosis in pre-eclampsia & intra-uterine growth restriction

Original classification

Research Grant

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.